Metformin ameliorates HMGB1-mediated oxidative stress through mTOR pathway in experimental periodontitis

Periodontitis is an oral chronic inflammatory disease. Inhibiting tissue destruction and promoting tissue regeneration are important means for the treatment of periodontitis. Metformin not only has hypoglycemic effect but also has anti-inflammatory effect. Metformin has been shown to inhibit oxidati...

Full description

Bibliographic Details
Main Authors: Boyang Sun, Siqi Ying, Qian Ma, Han Li, Jie Li, Jinlin Song
Format: Article
Language:English
Published: KeAi Communications Co., Ltd. 2023-03-01
Series:Genes and Diseases
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2352304221000830
_version_ 1797698956504858624
author Boyang Sun
Siqi Ying
Qian Ma
Han Li
Jie Li
Jinlin Song
author_facet Boyang Sun
Siqi Ying
Qian Ma
Han Li
Jie Li
Jinlin Song
author_sort Boyang Sun
collection DOAJ
description Periodontitis is an oral chronic inflammatory disease. Inhibiting tissue destruction and promoting tissue regeneration are important means for the treatment of periodontitis. Metformin not only has hypoglycemic effect but also has anti-inflammatory effect. Metformin has been shown to inhibit oxidative stress and activate autophagy through AMPK/mTOR pathway. High mobility group box 1 (HMGB1) has been implicated in the pathogenesis of many inflammatory diseases including periodontitis, it can participate in the induction of oxidative stress. HMGB1 is an autophagy regulator under oxidative stress, which can activate mTOR pathway. However, it is not clear whether metformin is related to HMGB1 and its mechanism in the process of periodontitis. Cell viability and expression of inflammatory cytokines were clarified by Cell Counting Kit-8, real-time PCR and enzyme-linked immunosorbent assay. Western blot and immunofluorescence were conducted to determine HMGB1 intracellular localization and expression of autophagy-associated proteins in vitro. Experimental periodontitis mice model was induced by administering a ligature. Immunohistochemistry was performed to detect the expression and localization of HMGB1 in vivo. The results of CCK-8, real-time PCR, enzyme-linked immunosorbent assay, Western blot and immunofluorescence showed lipopolysaccharide (LPS) treatment inhibited cell viability, and increased HMGB1 expression at a dose-independent manner. Metformin can reduce the effect of LPS. It also improves autophagy pathway inhibited by LPS and down-regulates mTOR expression. In addition, metformin attenuated alveolar bone resorption induced by ligation. This study provides new evidence for that metformin is a potential drug for the treatment of periodontitis and HMGB1 may be a potential target for periodontal intervention.
first_indexed 2024-03-12T04:01:29Z
format Article
id doaj.art-4ba4c7ec46df4998b04a11e77c6696cc
institution Directory Open Access Journal
issn 2352-3042
language English
last_indexed 2024-03-12T04:01:29Z
publishDate 2023-03-01
publisher KeAi Communications Co., Ltd.
record_format Article
series Genes and Diseases
spelling doaj.art-4ba4c7ec46df4998b04a11e77c6696cc2023-09-03T11:33:23ZengKeAi Communications Co., Ltd.Genes and Diseases2352-30422023-03-01102542553Metformin ameliorates HMGB1-mediated oxidative stress through mTOR pathway in experimental periodontitisBoyang Sun0Siqi Ying1Qian Ma2Han Li3Jie Li4Jinlin Song5College of Stomatology, Chongqing Medical University, Chongqing 400016, China; Chongqing Key Laboratory of Oral Diseases and Biomedical Sciences, Chongqing 400016, China; Chongqing Municipal Key Laboratory of Oral Biomedical Engineering of Higher Education, Chongqing 400016, ChinaCollege of Stomatology, Chongqing Medical University, Chongqing 400016, China; Chongqing Key Laboratory of Oral Diseases and Biomedical Sciences, Chongqing 400016, China; Chongqing Municipal Key Laboratory of Oral Biomedical Engineering of Higher Education, Chongqing 400016, ChinaCollege of Stomatology, Chongqing Medical University, Chongqing 400016, China; Chongqing Key Laboratory of Oral Diseases and Biomedical Sciences, Chongqing 400016, China; Chongqing Municipal Key Laboratory of Oral Biomedical Engineering of Higher Education, Chongqing 400016, ChinaCollege of Stomatology, Chongqing Medical University, Chongqing 400016, China; Chongqing Key Laboratory of Oral Diseases and Biomedical Sciences, Chongqing 400016, China; Chongqing Municipal Key Laboratory of Oral Biomedical Engineering of Higher Education, Chongqing 400016, ChinaCollege of Stomatology, Chongqing Medical University, Chongqing 400016, China; Chongqing Key Laboratory of Oral Diseases and Biomedical Sciences, Chongqing 400016, China; Chongqing Municipal Key Laboratory of Oral Biomedical Engineering of Higher Education, Chongqing 400016, China; Corresponding authors. College of Stomatology, Chongqing Medical University, 426# Songshibei Road, Yubei District, Chongqing 401147, China. Fax: +86 23 8886 0222.College of Stomatology, Chongqing Medical University, Chongqing 400016, China; Chongqing Key Laboratory of Oral Diseases and Biomedical Sciences, Chongqing 400016, China; Chongqing Municipal Key Laboratory of Oral Biomedical Engineering of Higher Education, Chongqing 400016, China; Corresponding authors. College of Stomatology, Chongqing Medical University, 426# Songshibei Road, Yubei District, Chongqing 401147, China. Fax: +86 23 8886 0222.Periodontitis is an oral chronic inflammatory disease. Inhibiting tissue destruction and promoting tissue regeneration are important means for the treatment of periodontitis. Metformin not only has hypoglycemic effect but also has anti-inflammatory effect. Metformin has been shown to inhibit oxidative stress and activate autophagy through AMPK/mTOR pathway. High mobility group box 1 (HMGB1) has been implicated in the pathogenesis of many inflammatory diseases including periodontitis, it can participate in the induction of oxidative stress. HMGB1 is an autophagy regulator under oxidative stress, which can activate mTOR pathway. However, it is not clear whether metformin is related to HMGB1 and its mechanism in the process of periodontitis. Cell viability and expression of inflammatory cytokines were clarified by Cell Counting Kit-8, real-time PCR and enzyme-linked immunosorbent assay. Western blot and immunofluorescence were conducted to determine HMGB1 intracellular localization and expression of autophagy-associated proteins in vitro. Experimental periodontitis mice model was induced by administering a ligature. Immunohistochemistry was performed to detect the expression and localization of HMGB1 in vivo. The results of CCK-8, real-time PCR, enzyme-linked immunosorbent assay, Western blot and immunofluorescence showed lipopolysaccharide (LPS) treatment inhibited cell viability, and increased HMGB1 expression at a dose-independent manner. Metformin can reduce the effect of LPS. It also improves autophagy pathway inhibited by LPS and down-regulates mTOR expression. In addition, metformin attenuated alveolar bone resorption induced by ligation. This study provides new evidence for that metformin is a potential drug for the treatment of periodontitis and HMGB1 may be a potential target for periodontal intervention.http://www.sciencedirect.com/science/article/pii/S2352304221000830AutophagyMetforminOxidative stressPeriodontal ligament cellsPeriodontitis
spellingShingle Boyang Sun
Siqi Ying
Qian Ma
Han Li
Jie Li
Jinlin Song
Metformin ameliorates HMGB1-mediated oxidative stress through mTOR pathway in experimental periodontitis
Genes and Diseases
Autophagy
Metformin
Oxidative stress
Periodontal ligament cells
Periodontitis
title Metformin ameliorates HMGB1-mediated oxidative stress through mTOR pathway in experimental periodontitis
title_full Metformin ameliorates HMGB1-mediated oxidative stress through mTOR pathway in experimental periodontitis
title_fullStr Metformin ameliorates HMGB1-mediated oxidative stress through mTOR pathway in experimental periodontitis
title_full_unstemmed Metformin ameliorates HMGB1-mediated oxidative stress through mTOR pathway in experimental periodontitis
title_short Metformin ameliorates HMGB1-mediated oxidative stress through mTOR pathway in experimental periodontitis
title_sort metformin ameliorates hmgb1 mediated oxidative stress through mtor pathway in experimental periodontitis
topic Autophagy
Metformin
Oxidative stress
Periodontal ligament cells
Periodontitis
url http://www.sciencedirect.com/science/article/pii/S2352304221000830
work_keys_str_mv AT boyangsun metforminameliorateshmgb1mediatedoxidativestressthroughmtorpathwayinexperimentalperiodontitis
AT siqiying metforminameliorateshmgb1mediatedoxidativestressthroughmtorpathwayinexperimentalperiodontitis
AT qianma metforminameliorateshmgb1mediatedoxidativestressthroughmtorpathwayinexperimentalperiodontitis
AT hanli metforminameliorateshmgb1mediatedoxidativestressthroughmtorpathwayinexperimentalperiodontitis
AT jieli metforminameliorateshmgb1mediatedoxidativestressthroughmtorpathwayinexperimentalperiodontitis
AT jinlinsong metforminameliorateshmgb1mediatedoxidativestressthroughmtorpathwayinexperimentalperiodontitis